Clinical Trials Logo

Pitt Hopkins Syndrome clinical trials

View clinical trials related to Pitt Hopkins Syndrome.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT05165017 Not yet recruiting - Clinical trials for Pitt Hopkins Syndrome

Safety & Efficacy of AlloRx SC® in PTHS Patients

Start date: December 2021
Phase: Phase 1/Phase 2
Study type: Interventional

This study will evaluate the safety of AlloRx Stem Cells® in subjects with Pitt Hopkins syndrome ages 2-45 with a molecularly confirmed pathogenic mutation in TCF4 or 18q deletion including TCF4. Participants will receive mesenchymal stem cells infusions every 3 months for a year with completion of outcome measures to assess the efficacy of the product.